NCT06808503 NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
| NCT ID | NCT06808503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West Virginia University |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-10-02 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk screening, suicide risk assessment, safety planning, referral procedures, and follow-up care activities for adolescents receiving health services. The study will assess implementation outcomes, including suicide screening practices, identification of suicide risk, safety planning, and follow-up service delivery, as well as participant outcomes including suicidal ideation, depressive symptoms, satisfaction with services, suicidal behavior, safety plan utilization, and acute care utilization. Data collected across participating sites will be combined to evaluate the feasibility, acceptability, and preliminary effectiveness of the adapted Clinical Pathway. Protocol amendments resulted in consolidation of site-specific outcome measures into combined analyses across participating school-based health centers. The ClinicalTrials.gov record was updated to reflect the current protocol, study procedures, and planned statistical analyses.
Eligibility Criteria
Inclusion Criteria: * Youth who are receiving services at the school-based health centers to participate * Parents must be able to give legal consent for themselves and their children to participate * Youth and Parent must be English-speaking * Youth must also be able to give signed assent to participate * Youth must be cognitively and medically able to participate in study activities Exclusion Criteria: * Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.
Contact & Investigator
Mary Christensen, PhD, LICSW
PRINCIPAL INVESTIGATOR
West Virginia University
Frequently Asked Questions
Who can join the NCT06808503 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06808503 currently recruiting?
Yes, NCT06808503 is actively recruiting participants. Contact the research team at mary.christensen@mail.wvu.edu for enrollment information.
Where is the NCT06808503 trial being conducted?
This trial is being conducted at Morgantown, United States, Oak Hill, United States, Summersville, United States.
Who is sponsoring the NCT06808503 clinical trial?
NCT06808503 is sponsored by West Virginia University. The principal investigator is Mary Christensen, PhD, LICSW at West Virginia University. The trial plans to enroll 70 participants.